Background: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …

Objective—To study the efficacy of anti–miRNA-33 therapy on the progression of
atherosclerosis. Approach and Results—Ldlr−/− mice were injected subcutaneously with …

Atherosclerosis is a chronic inflammatory disease of the arterial wall. It is characterized by
subendothelial accumulation of low-density lipoprotein cholesterol, and its subsequent …

Aims: Atherosclerosis is the most common cause of cardiovascular disease, such as
myocardial infarc-tion and stroke. Previous study revealed that microRNA (miR)-134 …

Vascular smooth muscle cell (VSMC) proliferation and migration are vital to atherosclerosis
(AS) development and plaque rupture. MicroRNA-377-3p (miR-377-3p) has been reported …

MicroRNAs (miRNAs) are short non-coding RNAs involved in the regulation of gene
expression at the post-transcriptional level that have been involved in the pathogenesis of a …

The transformation of vascular smooth muscle cells [VSMC] into foam cells leading to
increased plaque size and decreased stability is a key, yet understudied step in …

Circulating levels of low-density lipoprotein cholesterol (LDL), and high-density lipoprotein
cholesterol (HDL) are two of the most important risk factors for the development of …

Background Cholesterol efflux from cells to apolipoprotein A‐I (apoA‐I) acceptors via the
ATP‐binding cassette transporters ABCA 1 and ABCG 1 is thought to be central in the …

MicroRNAs in atherosclerosis and lipoprotein metabolism : Current Opinion in
Endocrinology, Diabetes and Obesity MicroRNAs in atherosclerosis and lipoprotein …